Article
[Relationship between the acquired multi-drug resistance of human large cell lung cancer cell line NCI-H460 by cisplatin selection and p53 mutation].
Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases - 1 Feb 2005
Wang Tao, Xu Jun, Zhong Nan-shan
Abstract excerpt
OBJECTIVE: To explore the role of p53 mutation in the development of acquired multi-drug resistance during lung cancer chemotherapy. METHODS: A resistance large cell lung carcinoma cell line (H460/DDP) was established by high dose (50 micromol/L) cisplatin intermittent selection from its parental cell NCI-H460 that had wild type p53 (wtp53). Several multi-drug resistant proteins (MRP) including lung relative...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
